School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, 6997601, Tel Aviv, Israel.
Department of Neuroscience, Faculty of Medicine, The Ruth and Bruce Rappaport, Haifa, 3109601, Israel.
BMC Biol. 2024 Nov 28;22(1):276. doi: 10.1186/s12915-024-02076-9.
The β-adrenergic augmentation of cardiac contraction, by increasing the conductivity of L-type voltage-gated Ca1.2 channels, is of great physiological and pathophysiological importance. Stimulation of β-adrenergic receptors (βAR) activates protein kinase A (PKA) through separation of regulatory (PKAR) from catalytic (PKAC) subunits. Free PKAC phosphorylates the inhibitory protein Rad, leading to increased Ca influx. In cardiomyocytes, the core subunit of Ca1.2, Ca1.2α, exists in two forms: full-length or truncated (lacking the distal C-terminus (dCT)). Signaling efficiency is believed to emanate from protein interactions within multimolecular complexes, such as anchoring PKA (via PKAR) to Ca1.2α by A-kinase anchoring proteins (AKAPs). However, AKAPs are inessential for βAR regulation of Ca1.2 in heterologous models, and their role in cardiomyocytes also remains unclear.
We show that PKAC interacts with Ca1.2α in heart and a heterologous model, independently of Rad, PKAR, or AKAPs. Studies with peptide array assays and purified recombinant proteins demonstrate direct binding of PKAC to two domains in Ca1.2α-CT: the proximal and distal C-terminal regulatory domains (PCRD and DCRD), which also interact with each other. Data indicate both partial competition and possible simultaneous interaction of PCRD and DCRD with PKAC. The βAR regulation of Ca1.2α lacking dCT (which harbors DCRD) was preserved, but subtly altered, in a heterologous model, the Xenopus oocyte.
We discover direct interactions between PKAC and two domains in Ca1.2α. We propose that these tripartite interactions, if present in vivo, may participate in organizing the multimolecular signaling complex and fine-tuning the βAR effect in cardiomyocytes.
通过增加 L 型电压门控 Ca1.2 通道的传导性,β-肾上腺素能增强心脏收缩具有重要的生理和病理生理意义。β-肾上腺素能受体 (βAR) 的刺激通过分离调节 (PKAR) 和催化 (PKAC) 亚基来激活蛋白激酶 A (PKA)。游离的 PKAC 使抑制蛋白 Rad 磷酸化,导致 Ca 内流增加。在心肌细胞中,Ca1.2 的核心亚基 Ca1.2α 存在两种形式:全长或截短(缺乏远端 C 端(dCT))。信号效率被认为源自多分子复合物内的蛋白质相互作用,例如通过激酶锚定蛋白 (AKAP) 将 PKA (通过 PKAR) 锚定到 Ca1.2α。然而,AKAPs 对于异源模型中 βAR 对 Ca1.2 的调节并非必不可少,它们在心肌细胞中的作用也尚不清楚。
我们表明,PKAC 在心脏和异源模型中与 Ca1.2α 相互作用,独立于 Rad、PKAR 或 AKAPs。肽阵列测定和纯化重组蛋白的研究表明,PKAC 与 Ca1.2α-CT 的两个结构域直接结合:近端和远端 C 端调节结构域(PCRD 和 DCRD),它们也相互作用。数据表明,PCRD 和 DCRD 与 PKAC 具有部分竞争和可能同时相互作用的关系。缺乏 dCT(含有 DCRD)的 Ca1.2α 的 βAR 调节在异源模型中(Xenopus 卵母细胞)得以保留,但略有改变。
我们发现了 PKAC 与 Ca1.2α 中的两个结构域之间的直接相互作用。我们提出,如果这些三聚体相互作用存在于体内,它们可能参与组织多分子信号复合物并微调心肌细胞中βAR 的作用。